Benzofuran derived HIV protease inhibitors
US7981929B2 · kind B2 · utility
3Cited by
4References
35Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 2008 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Aug 27, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.